Brinks DEA Consulting Welcomes Daniel Dormont, One of the Nation’s Leading Controlled Substances Experts
Is the DEA’s non-retrievable standard too much? Maybe it’s time to change the non-retrievable standard?
Exciting Change in DEA Statutes: Pharmacy Delivery of Controlled Substances to Practitioners Expands Beyond MOUD
Case Study Hospitals Under Fire: Poor Prescribing Oversight Leads to Expensive Settlements, Is Your Hospital Monitoring the Prescriptions Written by Your Practitioners?
Why Congress Must Fix 21 U.S.C. 829a(a): The Hidden Impact of the SUPPORT Act on Patient Care. Do you know the serious issues this law created—and how they could be limiting access to treatment?
Is Your Emergency Dispensing Kit DEA Compliant? What Long Term Care Pharmacies and Long Term Care Facilities Need to Know
Breaking Marijuana News: Is the Trump Executive Order and Rescheduling of Marijuana Really a Good Thing? I would be interested in your thoughts?
